title: 10 years, still shifting gears.
abstract: Ten years into the modern biologics era, access- and cost-management techniques still aren't refined. Why has managing biologics proven so much harder than managing other drugs? What strategies might help payers face the challenges of the future?
authors.forename: Katherine T
authors.initials: KT
authors.lastname: Adams